5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.45▼ | 3.45▼ | 3.45▼ | 3.64▼ | 3.90▼ |
MA10 | 3.44▲ | 3.45▲ | 3.47▼ | 3.82▼ | 4.07▼ |
MA20 | 3.45▼ | 3.47▼ | 3.44▲ | 3.89▼ | 4.48▼ |
MA50 | 3.45▲ | 3.46▼ | 3.81▼ | 4.00▼ | 3.28▲ |
MA100 | 3.47▼ | 3.82▼ | 3.90▼ | 4.56▼ | 2.87▲ |
MA200 | 3.45▲ | 3.89▼ | 4.06▼ | 3.35▲ | 3.73▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | 0.004▲ | 0.024▲ | -0.059▼ | -0.153▼ |
RSI | 49.748▼ | 46.943▼ | 40.093▼ | 39.862▼ | 44.741▼ |
STOCH | 68.333 | 39.134 | 39.598 | 34.187 | 46.600 |
WILL %R | -33.333 | -72.414 | -42.857 | -76.351▼ | -83.721▼ |
CCI | 47.257 | -54.902 | -9.722 | -112.540▼ | -126.482▼ |
CDL | $TARA Dark Cloud Cover Candlestick Pattern Detected | Set Alert |
Thursday, May 01, 2025 01:10 PM
Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the ...
|
Monday, April 28, 2025 09:44 AM
Shares of Protara Therapeutics, Inc. (NASDAQ: TARA) tumbled 19% after the company released interim results from its ongoing Phase 2 ADVANCED-2 trial of TARA-002 in patients with Non-Muscle Invasive ...
|
Saturday, April 26, 2025 09:18 AM
(RTTNews) - Protara Therapeutics Inc.(TARA) announced updated results from ... of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 3.56 | 3.60 | 3.41 | 3.46 | 446,121 |
30/04/25 | 3.35 | 3.5498 | 3.28 | 3.50 | 559,100 |
29/04/25 | 3.51 | 3.53 | 3.36 | 3.385 | 602,174 |
28/04/25 | 4.09 | 4.09 | 3.11 | 3.52 | 2,631,767 |
25/04/25 | 4.19 | 4.50 | 4.10 | 4.32 | 440,734 |
24/04/25 | 4.23 | 4.28 | 4.10 | 4.11 | 345,844 |
23/04/25 | 4.09 | 4.59 | 4.09 | 4.20 | 602,347 |
22/04/25 | 3.90 | 4.07 | 3.78 | 3.94 | 1,298,716 |
21/04/25 | 3.92 | 4.04 | 3.82 | 3.85 | 290,982 |
17/04/25 | 4.01 | 4.10 | 3.90 | 3.90 | 448,243 |
|
|
||||
|
|
||||
|
|